BIO-Europe 2026

Accelerating Biopharma R&D Through High-Definition Multiplex Assay Technologies

Our Business Developer, Maria Luisa Marini, will be attending BIO-Europe 2026 in Cologne to connect with global distributors, biopharma innovators, CDMOs, and blood banks seeking to optimize their analytical workflows.

At Innobiochips, we transform complex biological testing into streamlined, data-rich processes. Our proprietary microarray platform and the turnkey OMNYS ecosystem enable high-definition multiplex analysis—evaluating up to 100 parameters simultaneously from micro-volumes of sample.

We are actively exploring partnerships and collaborations across the following key areas:

-Custom Multiplex Assays (RUO): Accelerating R&D and clinical programs through large-scale population screening, high-throughput antibody clone selection, vaccine development, and API characterization.

-Blood Bank Diagnostics: Deploying the OMNYS ecosystem for extended donor phenotyping and efficient rare blood group identification.

-Global Distribution: Engaging with distribution partners to commercialize our innovative RUO platforms

Whether you are looking to enhance your research capabilities, explore custom assay development, or discuss commercial distribution opportunities, We would welcome the opportunity to connect.

Maria -Luisa is available for 15-minute introductory meetings via the official BIO-Europe partnering platform, you can reach out directly via LinkedIn message or by mail ([email protected]) to schedule a discussion.